APA (7th ed.) Citation

S, S., E, D. B., T, K., N, R., JA, H., C, W., . . . L, P. (2021). Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis. Neurology, 97(19), e1870. https://doi.org/10.1212/WNL.0000000000012753

Chicago Style (17th ed.) Citation

S, Simpson-Yap, et al. "Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis." Neurology 97, no. 19 (2021): e1870. https://doi.org/10.1212/WNL.0000000000012753.

MLA (9th ed.) Citation

S, Simpson-Yap, et al. "Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis." Neurology, vol. 97, no. 19, 2021, p. e1870, https://doi.org/10.1212/WNL.0000000000012753.